A novel class of pharmaceuticals which comprises a Locked Nucleic Acid (LNA) which can be used in antisense therapy. These novel oligonucleotides have improved antisense properties. The novel oligonucleotides are composed of at least one LNA selected from beta-D-thio/amino-LNA or alpha-L-oxy/thio/amino-LNA. The oligonucleotides comprising LNA may also include DNA and/or RNA nucleotides.

 
Web www.patentalert.com

< Regulators of the hedgehog pathway, compositions and uses related thereto

< 9-Ketospinosyn derivatives

> Novel oligonucleotides and treating cardiac disorders by using the same

> Stress tolerance and delayed senescence in plants
~ 00269